Article

Contact lens intolerant allergy sufferers find relief

Author(s):

Wantagh, NY-Results of a multicenter, randomized, open-label study demonstrate that twice-daily epinastine HCl 0.05% ophthalmic solution (Elestat, Inspire Pharmaceuticals and Allergan) has significant value compared with use of rewetting drops only for improving comfort among allergy patients suffering with contact lens intolerance.

The study was conducted during the spring allergy season. It enrolled 149 patients with allergic conjunctivitis and properly fitting daily-wear lenses who were complaining about contact lens intolerance at a screening visit and continued to have problems after a 5- to 7-day run-in period using rewetting drops (Equate) twice daily.

Patients were randomly assigned to use epinastine twice daily with rewetting drops as needed or to twice-daily treatment with rewetting drops, with additional rewetting drops as needed. The patients in the epinastine group were directed to instill their anti-allergy treatment 15 minutes prior to contact lens insertion and again after removal.

Compared with rewetting drops, epinastine provided benefits for improving the duration of comfortable lens wear and total lens wearing time, ocular itching severity, overall eye comfort, and need for self-medication with rewetting drops, reported Jodi Luchs, MD, FACS. He is director, Department of Refractive Surgery, North Shore Long Island Jewish Health System, Great Neck, NY; assistant clinical professor of ophthalmology and visual sciences, Albert Einstein College of Medicine, New York; and in private practice at South Shore Eye Care, Wantagh, NY.

Contact lens discomfort

"Reduced contact lens comfort can have detrimental effects on work performance, impair enjoyment of leisure time, interfere with the ability to perform activities of daily living, and reduce self-perception of appearance if patients switch from contact lens to spectacle wear," he added. "Therefore, clinicians should not overlook the potential for effective treatment of allergies that are causing contact lens intolerance to have important secondary benefits not measured in this study."

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.